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Abstract
Background: Adult mesenchymal stem cells (MSCs) can be conveniently sampled from bone marrow, peripheral
blood, muscle, adipose and connective tissue, harvested from various species, including, rodents, dogs, cats, horses,
sheep, goats and human beings. The MSCs isolated from adult tissues vary in their morphological and functional
properties. These variations are further complicated when cells are expanded by passaging in culture. These
differences and changes in MSCs must be considered prior to their application in the clinic or in a basic research
study. Goats are commonly used as animal models for bone tissue engineering to test the potential of stem cells
for bone regeneration. As a result, goat MSCs isolated from bone marrow or adipose tissue should be evaluated
using in vitro assays, prior to their application in a tissue engineering project.
Results: In this study, we compared the stem cell properties of MSCs isolated from goat bone marrow and adipose
tissue. We used quantitative and qualitative assays with a focus on osteogenesis, including, colony forming unit, rate of
cell proliferation, tri-lineage differentiation and expression profiling of key signal transduction proteins to compare
MSCs from low and high passages. Primary cultures generated from each source displayed the stem cell characteristics,
with variations in their osteogenic potentials. Most importantly, low passaged bone marrow MSCs displayed a
significantly higher and superior osteogenic potential, and hence, will be the preferred choice for bone tissue
engineering in future in vivo experiments. In the bone marrow MSCs, this process is potentially mediated by the p38
MAPK pathway. On the other hand, osteogenic differentiation in the adipose tissue MSCs may involve the p44/42
MAPK pathway.
Conclusions: Based on these data, we can conclude that bone marrow and fat-derived MSCs undergo osteogenesis
via two distinct signaling pathways. Even though the bone marrow MSCs are the preferred source for bone tissue
engineering, the adipose tissue MSCs are an attractive alternative source and undergo osteo-differentiation differently
from the bone marrow MSCs and hence, might require a cell-based enhancer/inducer to improve their osteogenic
regenerative capacity.
Keywords: Caprine mesenchymal, Osteogenesis stem cells
* Correspondence: mdhar@utk.edu
1Department of Large Animal Clinical Sciences, University of Tennessee,
Knoxville, TN 37996, USA
Full list of author information is available at the end of the article
© 2016 Elkhenany et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Elkhenany et al. Journal of Animal Science and Biotechnology  (2016) 7:16 
DOI 10.1186/s40104-016-0074-z
Background
There has been an explosion of research publications in
the field of mesenchymal stem cells (MSCs) in the past
10 yr. Many researchers have sought to exploit their po-
tential as a source of reparative cells for clinical use in a
variety of contexts [1]. Adult stem cells are multipotent,
undifferentiated, self-renewing capable of healing and re-
generation of injured tissues [2–4]. Adult MSCs were
initially identified in bone marrow (BM) and since then
have been isolated and characterized from different hu-
man and animal adult tissues, peripheral blood, adipose,
muscle, skin, dental pulp and other tissues [5–10].
Adult stem cells can be conveniently sampled from an
extensive array of sources bypassing the ethical contro-
versy associated with the embryonic stem cells, which is
increasingly affecting the use of stem cell research and
therapy. Even though, MSCs can be isolated from a var-
iety of tissues and species, there is significant variation
in their biological properties (morphological and func-
tional changes) [11–17]. These changes can be due to
the source of MSCs, age-dependent donor-to-donor
variation, and due to the signaling pathways that each
cell type undergoes during differentiation. These varia-
tions are further complicated when cells are expanded
by passaging in culture. Cell cultures generated from
MSCs are not immortalized cell lines but are primary
cultures which have limited lifespan and they undergo
the process of senescence and stop dividing after a cer-
tain number of population doublings while generally
retaining their viability [18]. These are inherent chal-
lenges associated with the in vitro expansion of primary
cultures of MSCs. As cells divide in culture, they grow
and fill the available area or volume and reach con-
fluency when the given area is filled. If the cells become
over-confluent, cell-to-cell contact can stimulate cell
cycle arrest, causing cells to stop dividing, cell-to-cell
contact can stimulate cellular differentiation, and genetic
and epigenetic alterations can occur, potentially leading
to overgrowth of abnormal, culture-adapted cells with
decreased differentiation and increased proliferative
capacity [19]. All these cell culture issues can directly or
indirectly affect the biological function of cells obtained
during passaging. Passaging of MSCs is important and
necessary to obtain enough cell numbers for clinical
applications. Hence, for controlled animal model experi-
ments, we need to investigate and compare the proper-
ties of MSCs from different sources at harvest and
during passaging, prior to their use in these
experiments.
The most extensively used sources of undifferentiated
MSCs are bone marrow and adipose tissue. Bone
marrow aspirates contain only small proportion of MSCs
and their number and differentiation capacity decrease
with age of donors [20]. While, adipose tissue is
abundant, relatively easy to access from the body and
the cell numbers do not decrease with the age [6].
Goats are widely used as large animal preclinical
model for bone tissue engineering. Goats have a body
weight similar to that of human beings, which mimics
the same load bearing factors on human fracture. The
metabolic rate of goats is similar to that of humans and
most importantly, goats have a body size suitable for im-
plantation of implants and prostheses [21–24]. The
focus of our research is bone tissue engineering, hence,
in this study, experiments were designed to compare
and assess the cell culture properties of bone marrow-
and fat-derived goat MSCs and to investigate whether
these MSCs undergo any biological changes when they
are expanded in culture. This comparison would then be
used to identify the optimal source of goat MSCs for
bone tissue engineering. We hypothesize that MSCs de-
rived from bone marrow and adipose tissue differ in
their proliferation and osteogenic potentials which may
be affected at multiple levels. To prove our hypothesis,
we compared goat/caprine bone marrow - derived MSCs
from low (cBMMSCslow), and high (cBMMSCshigh)
passages to the adipose - derived MSCs from identical
passage numbers (cADMSCslow and cADMSCshigh).
Comparison was made by assessing their proliferation
capacity, trilineage differentiation and expression profile
of osteogenic specific proteins.
Methods
Media and chemicals
All chemicals, cell culture supplements, and disposable
tissue culture supplies were purchased from Thermo
Fisher Scientific (Fisher Scientific, Pittsburgh, PA) unless
otherwise noted. Animal experimental procedures were
carried out according to protocols approved by the Insti-
tutional Animal Care and Use Committee.
Tissue collection and isolation of MSCs
Goat adipose-derived MSCs were isolated and expanded
in tissue culture using methods previously reported for
equine and goat fat [11, 25]. Briefly, 5 g of subQ adipose
tissue was harvested from the inguinal area of a 2 - year
- old mixed breed goat. Subsequently, the tissue was
rinsed with a 10 % bleaching solution for disinfection
and, after washing thoroughly with 1× PBS, was minced
into small pieces. Tissue was then digested in a mixture
of 2 mg/mL collagenase (Type I; 260U, and type IV;
220U) solution in 1× PBS with continuous shaking at
37 °C for 40 min. The digested sample was filtered
through a 100 micron cell strainer and centrifuged at
800 g for 10 min at 10 °C, resulting in a stromal vascular
fraction (SVF) pellet. The pellet was resuspended in
medium consisting of Dulbecco’s modified medium-F12,
with 10 % fetal bovine serum and 100 I.U./mL penicillin,
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100 μg/mL streptomycin (referred to as the growth
medium). Roughly, 2–4 × 106 cells/5 g of tissue were ob-
tained and seeded in T75 culture flasks in growth media
and allowed to adhere for 48 h. Stromal medium was
changed every 3 d until the cells reached 80 % con-
fluency. Adherent cADMSCs were passaged by digestion
with 0.25 % trypsin/EDTA.
Previously isolated, characterized and cryopreserved
goat bone marrow-derived MSCs were used in all exper-
iments [26].
All experiments were carried out simultaneously using
the cADMSCs and cBMMSCs. In all experiments, pas-
sages 2–3 were considered as the lower passage, and
passage 12-14 was considered as higher passages. Hence,
4 cell types were investigated in this study. These are re-
ferred to as: cBMMSCslow, cBMMSCshigh, cADMSCslow,
and cADMSCshigh.
Colony forming unit (CFU) assays
Freshly isolated mononuclear cells present in the bone
marrow buffy coat (Passage 0) and 1× 103 cBMMSCs of
passage 3 and passage 12 each were seeded in 100 mm
tissue culture dishes. Similarly, a portion of digested fat
remaining after collagenase digestion and representing
passage 0 and 1× 103 cADMSCs of passage 3 and pas-
sage 12 each were seeded in 100 mm tissue culture
dishes. After incubation for 7 d in a 37 °C, 5 % CO2
incubator, cells were washed with PBS and fixed with
10 % formalin for 10 min at room temperature. Subse-
quently, the colonies were stained with 0.5 % crystal vio-
let solution for 5 min at room temperature, and imaged
using Zeiss Axiovert 40C microscope (Carl Zeiss MicroI-
maging, Inc., Thornwood, NY, USA) equipped with
Nikon Digital Sight DS-Qi1Mc camera (Nikon Instru-
ments Inc., Melville, NY, USA).
Cell proliferation assay
Cells from cBMMSCslow, cBMMSCshigh, cADMSCslow,
and cADMSCshigh at density of 5×103/well were seeded
in 24 well tissue culture plates. Cell proliferation were
measured at d2, d7 and d10 using CellTitre 96® Aqueous
nonradioactive (MTS) assay (Promega, Madison, WI) ac-
cording to the manufacturer’s instructions. Briefly, MTS
reagent prepared in a 5:1 ratio relative to the media was
added to the cells and incubated for 3 h at 37 °C and 5
% CO2. Then 100 μL (n = 3) was transferred to 96-well
Fig. 1 Colony forming assay. A representative photograph of a freshly isolated bone marrow-derived mononuclear cells (passage 0) b cBMMSCs
passage 3 c cBMMSCs passage 13 d Stromal vascular fraction (SVF) of adipose tissue e cADMSCs passage 3 and f cADMSCs passage 11. Clusters
of colonies were visualized by crystal violet staining. Scale bar = 100 μm
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plate and the absorbance was measured at 490 nm. Non
seeded wells with media only were used as blank.
Tri-lineage differentiation assays
Osteogenesis, chondrogenesis, and adipogenesis were
performed as described earlier with slight modifications
[26]. Roughly 2×105 cells were seeded in complete
growth media, and 48 h later, when cells were 70 % con-
fluent, lineage-specific differentiation was induced. Cells
were exposed to specific differentiation media through-
out the differentiation process and media was replen-
ished every 3 d. For each differentiation assay, an
identical number of non-induced cells (cells without any
differentiation media) were used as controls. Tri-lineage
differentiation was monitored and visualized using phase
contrast microscopy and cell-specific staining. Alizarin
red staining at d21, alcian blue staining at d14, and oil-
red-o staining at d7, for osteogenesis, chondrogenesis,
and adipogenesis, respectively were used. All images
were obtained using a Zeiss Axiovert 40C microscope
(Carl Zeiss MicroImaging, Inc., Thornwood, NY, USA)
equipped with Nikon Digital Sight DS-Qi1Mc camera
(Nikon Instruments Inc., Melville, NY, USA).
Osteogenic and chondrogenic differentiation assays
Quantitative assays were carried out at d7, d14 and d21
using methods described earlier [27, 28]. For osteogenic
quantitation, alizarin red was extracted using 10 % cetyl-
pyridium chloride for 30 mins. and the color was de-
tected at 550 nm. For chondrogenic quantitation, alcian
blue was extracted using 6 mol/L guanidine hydrochlor-
ide for 24 h, and the color was detected at 620 nm.
Western blot analysis
To obtain whole cell protein extracts, low and high
passaged undifferentiated and osteo-differentiated
cADMSCs and cBMMSCs at d7, d14 and d21 were
collected in cell lysis buffer (Boston Bioproducts, Ash-
land, MA). Whole cell extracts were sonicated and
centrifuged to obtain the total proteins. Total protein
Fig. 2 MTS assay. Comparison of proliferation of cBMMSCs and cADMSCs low and high passage over the period of 10 days. Significantly different
values (P < 0.05) are indicated by superscript letters. Identical letters indicate no significance
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in each sample was quantitated and concentrations
were obtained using the BCA assay (Pierce, Thermo
Scientific, Rockford, IL).
For western blot analysis, 25 μg of proteins were electro-
phoretically separated by 10 % SDS-polyacrylamide gel
electrophoresis and transferred to nitrocellulose mem-
branes. The membranes were blocked with 5 % bovine
serum albumin and incubated with 1–5 μg of primary
antibodies against β-Tubulin (Santa Cruz, Dallas, Texas),
osteopontin, (Abcam, Cambridge, MA), BMP-7, (Milli-
pore, Darmstadt, Germany), p38 MAPK (Cell signaling,
Danvers, MA), and p44/42 MAPK(Cell Signaling) pro-
teins. Bound proteins were visualized with HRP-
conjugated anti-rabbit IgG for β-Tubulin, osteopontin,
p38 and p44/42, or anti-mouse IgG for BMP-7. Enhanced
Chemiluminescence assay was used for the visualization
of the protein bands. The intensity of each band was ana-
lyzed using Image J software (Image j 1.48 V, Wayne Ras-
band, National institutes of health, USA, http://
imagej.nih.gov/ij, Java 1.6.0–20 (64-bit).
Immunofluorescence (IF)
Undifferentiated and differentiated cells were stained
with osteogenic-specific protein, osteopontin on d21.
For staining, cells were fixed with 4 % paraformaldehyde,
blocked with 5 % normal serum for 30 min at room
temperature and finally incubated with 5 μg of anti-
osteopontin (Abcam). Osteopontin was detected using
Alexa Fluor 647 donkey anti-rabbit IgG. The cells were
mounted with SlowFade Gold Antifade with DAPI re-
agent (thermo Fisher Scientific, Waltham, MA) and im-
ages were taken with a laser scanning spectral confocal
microscope (Leica TCS SP2; Leica Microsystems©, Wet-
zlar, Germany).
Statistics
All quantitative data are presented as mean ± standard
deviation (SD) with no less than three replicates for each
experimental condition. Comparison between experi-
mental and control groups were performed with Factor-
ial ANOVA with the use of SAS Enterprise Guide 6_1. A
value of P <0.05 was considered statistically significant.
Results and discussion
Stem cell characteristics
Adult mesenchymal stem cells were isolated from goat
(caprine) subQ fat and sternal bone marrow aspirate.
Cells isolated from each of these sources were character-
ized by assessing their in vitro adherence, proliferation,
and tri-lineage differentiation profiles. Each of these
characteristics were compared between cBMMSCslow,
cBMMSCshigh, cADMSCslow, and cADMSCshigh.
1- Colony forming unit (CFU) and Cell proliferation
assay
Our results confirmed that the cells from the mono-
nuclear fraction of goat bone marrow and the SVF from
goat subQ fat contain the mesenchymal progenitor cells
which are capable of adherence to tissue culture surface,
proliferation to form a cluster of colonies and providing
sufficient number of cells within 7 d. These properties
were maintained even at higher passages. However, some
striking differences were observed.
Fig. 3 Adipogenesis differentiation. Comparison of cBMMSCs and cADMSCs, undergoing adipogensis as detected by the formation of neutral
lipid vacuoles stained with Oil Red-O at 21 days after induction a cBMMSCsLow 10X b cBMMSCsHigh 10X c cADMSCsLow 10X d cADMSCsHigh 5X
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Subjective evaluation using CFU assay revealed that all
4 MSC cultures were capable of growing in clusters
(Fig. 1). Cell viability and proliferation as judged by the
MTS assay however, showed significant differences
(Fig. 2). Both the cBMMSCslow and cADMSCslow prolif-
erated over the course of 10 d and cell numbers in-
creased 11–15 fold significantly with time. Specifically,
the cBMMSCslow and cADMSCslow demonstrated a
Fig. 4 Chondrogenesis differentiation. Comparison of cBMMSCs and cADMSCs. a chondrogenesis as detected by alcian blue staining at d 14
after induction (a) cBMMSCsLow, 5X (b) cBMMSCsHigh, 5X (c) cADMSCsLow, 5X (d) cADMSCsHigh, 5X. b Graph representing normalized alcian blue
staining (indicating the GAG content in the chondrocyte differentiated cBMMSCs and cADMSCs from low and high passages). Dotted line
indicates the GAG content in undifferentiated cells normalized to 100. Significantly different values (P < 0.05) represent the comparison between
the three time points within a specific group. Identical letters indicate no significance
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Fig. 5 (See legend on next page.)
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significantly higher rate of proliferation between d2 and
d10. Additionally, as judged by the regression analyses,
there was a linear increase in proliferation in
cBMMSCslow and cADMSCslow only in this time period.
This pattern however, was not maintained in the higher
passaged cells. Cells from cBMMSCshigh and cADMSC-
shigh did not proliferate linearly over the same time
period, cell numbers increased roughly 3–5 folds only,
and there was no significant difference between their
rates of proliferation. The difference in proliferation be-
tween cBMMSCs and cADMSCs is similar to that re-
ported earlier in human [17] and sheep [29] studies,
however, it disagrees with the data reported by Zhu et al
who demonstrated that human ADMSCs proliferate
higher than BMMSCs [30]. The comparison between
passage numbers is unique to our study.
2- Tri-lineage differentiation assays
Low and high passaged MSCs from both sources
underwent tri-lineage differentiation, with some mor-
phological differences (Figs. 3, 4 and 5).
Adipogenic differentiation
The cBMMSCslow demonstrated clusters of large fat oil-
red-o positive droplets, whereas, cADMSCslow exhibited
relatively small and dispersed droplets. The pattern of
adipogenic differentiation in the high passaged cells
from both sources was intriguing. Even though the cells
were induced towards adipogenic differentiation, the dif-
ferentiated cells appeared morphologically similar to
chondrocytes (Fig. 3b & d). Typically, when MSCs are
submitted to chondrogenic conditions in monolayer cul-
ture, they begin to condensate in response to the stimu-
lus and form high-density three-dimensional cell
aggregates [31]. Subjectively, a cell aggregate–like pat-
tern described above and suggesting chondrogenesis was
observed in the cADMSChigh cells. This observation is
supported by previous studies [32, 33]. Nujib Ullah et al.
showed that adipogenic ECM was positive for
chondrocyte-specific proteins, collagen I, type II and IV,
and also, demonstrated alkaline phosphatase activity in-
dicating the ossified nature [33].
Chondrogenic differentiation
Subjective evaluation of chondrogenic differentiation
(Fig. 4a) in all cell lines, exhibited similar patterns of dif-
ferentiation. However significant differences, were ob-
served in the level of chondrogenesis as measured by the
GAG contents (Fig. 4b). The accumulation of GAGs sig-
nificantly increased with time for each of the 4 cell lines,
suggesting that cells from all sources had the potential
to undergo chondrogenesis. There were no significant
differences within the different cell sources; differences
however, were significant between the passage numbers.
For instance, cBMMSCslow and cADMSCslow both
showed a significant increase in GAG content at d 14
(P < 0.05). The cBMMSCshigh and cADMSCshigh, how-
ever, showed a significant increase at d 21 (P < 0.05), sug-
gesting delayed chondrogenesis in high passaged cells.
These findings are supported by previous studies which
report that the chondrogenic potential of canine and
mouse MSCs is dependent on the age of the donor and
the serial passaging of cells in culture [20, 34].
Results presented above demonstrate that the primary
cultures of goat BM and ADMSCs undergo changes
when they are passaged in culture, and these changes
affect their proliferation, adipogenesis and chondrogene-
sis differentiations. Further investigations are required to
fully understand these changes, but, are beyond the
focus of this paper.
Osteogenic differentiation
Since, the focus of this study is to use goat as a preclin-
ical model of bone tissue engineering, detailed experi-
ments to assess the process and mechanism of
osteogenesis differentiation in the four MSC cultures
were carried out (Fig. 5). Subjective evaluation of osteo-
genic differentiation (Fig. 5a), exhibited significant differ-
ences in alizarin red staining in all cell lines. Presence of
alizarin red stained mineralized nodules coupled with a
significant increase in the calcium content (Fig. 5b),
demonstrates that low passaged bone marrow-derived
MSCs have the highest potential to undergo in vitro
osteogenesis. This data is supported by the in vivo find-
ings reported by Niemeyer et al and Xie et al., that the
bone healing potential of BMMSCs was higher than the
ADMSCs in sheep [35] and in rabbit [36].
(See figure on previous page.)
Fig. 5 a Osteogenesis differentiation. Comparison of cBMMSCs and cADMSCs. Osteogenesis as detected by the formation of mineralized nodules
stained with alizarin red at d 21 after induction (a) cBMMSCsLow, 5X (b) cBMMSCsHigh, 5X (c) cADMSCsLow, 5X (d) cADMSCsHigh, 5X. b Graph
representing normalized alizarin red staining (indicating the calcium content in the mineralized nodules in the osteocyte differentiated cBMMSCs
and cADMSCs from low and high passages). Dotted line indicates the alizarin content in undifferentiated cells normalized to 100. Significantly
different values (P < 0.05) represent the comparison between the three time points within a specific group. Identical letters indicate no
significance. c The cADMSCshigh have a tendency to undergo adipogenesis and cell senescence in presence of osteogenic differentiation
medium. (a) Alizarin red staining – note the lack of staining and mineralized nodules, 10X (b) Oil Red-O staining – note the staining in a focused
area during osteogenesis, 20X (c) Calcein am, – note the bright green fluorescence demonstrating viable cells, 10X (d) Propidium iodide – note
the red fluorescence demonstrating the dead cells, 10X
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The effect of serial passaging of cells on the osteogenic
differentiation is unique to our study. When the
cBMMSCshigh and cADMSCshigh were induced to
undergo osteogenic differentiation, the cells did differen-
tiate into osteocytes but, could not form mineralized
nodules, suggesting a poor potential for differentiation.
This was confirmed by the significantly low alizarin red
content and the lack of mineralized nodules in the ali-
zarin red staining (Fig. 5a and; b).
Another intriguing observation was that the cADMSC-
shigh exhibited adipocyte morphology when they were in-
duced to differentiate into osteocytes, indicating a
change in their property on passaging. Additionally, as
judged by the presence of red fluorescence when stained
with propidium iodide, majority of the differentiated
cells were not viable (Fig. 5c). The results suggest that
on passaging the cADMSCshigh might lose their poten-
tial for osteogenesis and cannot survive the presence of
exogenously added growth factors. Interestingly, the oil-
red-o staining in these cells demonstrated that the cells
had undergone adipogenesis (Fig. 5c (b)). These results
are in agreement with the data reported by Jaiswal et al.
that when osteogenic differentiation is blocked using
MAPK signaling, stem cells undergo adipogenic differen-
tiation [37]. The exact mechanism of all these changes
in the higher passaged cells is not known. We can only
deduce that on culturing the cADMSCs undergo major
morphological changes which can potentially affect their
function and hence, should be considered prior to their
use. Finer analysis revealed that the osteogenic potential
of fat-derived MSCs is considerably reduced after 3–4
passages, whereas, bone marrow-derived MSCs retained
this potential up to passage 6.
Taken together, even though MSCs from all 4 sources
proliferate and undergo tri-lineage differentiation, the
low passaged bone marrow-derived MSCs described in
this study exhibit properties that present them as the op-
timal source of MSCs for bone tissue engineering.
Mechanism of osteogenesis
The precise cellular signaling mechanisms by which
bone synthesis is controlled within the progenitor cells
remains undefined. The process more likely includes
early electrophysiological responses, possibly mediated
by intra– and extra– cellular signaling pathways, i.e. reg-
ulated by transcription factors at the transcriptional level
and/or expression of key proteins at the translational
level. All these processes can thus regulate the osteoblast
phenotype [38]. In order to assess the mechanism of
osteogenesis in each of the four MSC primary cultures
generated in this study, a combination of immunofluor-
escence and immunoblotting analyses were used and the
expressions of key target proteins, including, osteopon-
tin, p38, p44/42 and BMP-7, known to have major bio-
logical roles in specific phases of the osteogenesis
process were investigated. Our goal was to try and
Fig. 6 Immunofluorescence analyses. Detection of osteogenic specific markers in cBMMSCs and cADMSCs. Immunofluorescence showing the
expression of OPN in a cBMMSCsLow, 20X b cADMSCsLow, 20X c cBMMSCsHigh, 20X d cADMSCsHigh, 20X
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understand what makes one MSC culture better suited
for osteogenesis compared to the other. Understanding
the mechanism and identifying the key molecular and
cellular factors of osteogenesis expressed in bone mar-
row or fat MSCs, may be useful for developing new
treatment strategies to improve the osteogenic potential
of MSCs which in turn will accelerate bone formation,
necessary for bone tissue engineering.
Osteopontin (OPN), is a protein expressed in the
bone-related matrix and is generally considered to be a
specific marker expressed in the late stage of osteogenic
differentiation [39–41]. Hence, OPN is expressed in cells
with a potential to undergo osteogenesis, and its expres-
sion should increase with differentiation [42].
Results in Figures 6 and 7 show the expression of
OPN in undifferentiated and differentiated MSCs from
all sources, suggesting that MSCs have the potential to
undergo osteogenesis. Significant up-regulation of OPN
and significant increase in the alizarin red content
(Figs. 5b & 6) in differentiated cBMMSCslow data con-
firms that the cBMMSCs low have the highest potential
to undergo osteogenesis. The expression level of OPN
protein can be considered as a good indicator of osteo-
genic differentiation potential. This pattern of expression
is further confirmed by the quantitative osteogenic
assay.
Mitogen-activated protein kinase (MAPK) pathway is
a chain of proteins in the cell that communicates a sig-
nal from a receptor on the surface of the cell to the
DNA in the nucleus. The MAPK signaling pathway
comprises of a cascade of three protein kinases: extracel-
lular signal-regulated kinase (ERK), p38, and c-Jun NH2-
terminal kinase (JNK), and control a variety of important
cellular events, including, cell proliferation, apoptosis
and differentiation [43–46]. The exact role of MAPK
proteins in the osteogenesis process is unclear. Several
Fig. 7 Immunoblot analyses. Western blots showing the expression of OPN, BMP-7, p38 and p44/42 in low and high passaged cBMMSCs and
cADMSCs. Autoradiographs of undifferentiated (lanes 1, 2, 3) and differentiated (lanes 4, 5, 6) cells at three time points, d 7, 14, 21 are shown.
Graphs represent the relative expression of each protein in the differentiated samples normalized with that in the undifferentiated samples. β
tubulin was used as a housekeeping control. Dotted line indicates the protein expression in undifferentiated cells normalized to 100. Significantly
different values (P < 0.05) represent the comparison between the three time points within a specific group. Identical letters indicate
no significance
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reports suggest their pro – or the anti- effect on this
process [43–50]. Of relevance to this study, recent find-
ings suggest that the MAPK pathway has a regulatory
role in the osteogenesis process. The JNK and ERK path-
ways are repressors of osteogenesis, whereas p38 path-
way is an enhancer of osteogenesis of BMMSCs [47, 48,
50].
Western blot analysis data showed that both the p38
and OPN proteins were significantly up-regulated on
d21 when cBMMSCslow differentiated into osteocytes,
suggesting that the osteogenic differentiation in these
cells is mediated by p38 and not p44/42 proteins (Fig. 7).
These findings are in agreement with some of the previ-
ous studies [48, 50], which reported that blocking of
ERK pathway promoted ALP activity and mineralization.
This pattern was however, not observed in the
cBMMSCshigh.
Comparatively, p44/42 was significantly up-regulated
in cADMSCslow and high suggesting its involvement in
osteogenesis of adipose – derived MSCs (Fig. 7). Add-
itionally, bone morphogenetic protein 7 (BMP-7), an-
other protein known to have a role in osteo-
differentiation [51, 52] was significantly up-regulated in
cADMSCs low and high, while its expression in
cBMMSCslow and high were significantly lower than in the
cADMSCs. Results suggest that BMP-7 may have a role
in osteogenic differentiation in fat-derived MSCs and
not bone marrow – derived MSCs. The exact role of
BMP-7 is controversial. Knippenberg et al. demonstrated
that BMP-7 is involved in the chondrogenesis of
adipose-derived MSCs; whereas, Katja et al. reported
that BMP7 is required in the adipogenic differentiation
of bone marrow MSCs [53, 54].
In summary, all data suggest that the MSC population
of cells cultured from goat bone marrow and fat have
the potential to undergo osteogenic differentiation in
vitro under optimal culture conditions. The MSCs from
both sources undergo changes during passaging, the
exact mechanism of which is still unclear. Results pre-
sented in this study demonstrate that the process of
osteogenic differentiation of MSCs, is mediated by dif-
ferent protein factors in bone marrow and adipose tis-
sue. As judged by the OPN expression and quantitatively
confirmed by the osteogenic assay, the cBMMSCslow
osteogenesis is probably mediated by p38. On the other
hand, osteogenic differentiation in cADMSCslow is medi-
ated via p44/42 and BMP-7 signaling. Differences in sig-
naling during differentiation can impact their function.
Based on our results, we propose that MSCs from
either the bone marrow or the adipose tissue are naïve,
undifferentiated stem cells which have the potential to
differentiate into osteocytes, chondrocytes and
Fig. 8 Schematic representation of the proposed mechanism of osteogenesis. Key targets involved and potential signaling networks regulating
the osteogenesis of cBMMSCs and cADMSCs
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adipocytes. When they are exposed to the osteogenic
signals, the cells have the potential to undergo osteo-
genic differentiation via the p38 or the p44/42 MAPK
pathways. The BMMSCs potentially undergo osteogen-
esis via p38 resulting in the up-regulation of OPN and
the alizarin red content, thus demonstrating an efficient
differentiation process. Comparatively, the AdMSCs
could potentially differentiate via p44/42 which leads to
an up-regulation of BMP-7 and thus the cells can differ-
entiate into osteocytes, chondrocytes or adipocytes. As a
result, the osteogenic differentiation is not as efficient
and the numbers of osteocytes and mineralized nodules
are much lower than that in BMMSCs. Our proposed
model to describe these variations in BM and ADMSCs
is illustrated in Fig. 8.
Conclusion
In conclusion, the adult MSCs isolated from goat bone
marrow and adipose tissue exhibit differences in their
proliferation and osteogenic differentiation when they
are cultured in vitro. These differences are in part, due
to the source and passaging of MSCs, and the distinct
signaling pathways that the MSCs go through during
differentiation.
Serial passaging of MSCs from both sources results in
reduced proliferation and osteogenic differentiation, the
exact mechanism of which could not be determined
from the reported data. The ADMSCs is an attractive
source for MSCs but low passaged (<3) cells should be
used for therapy. Comparatively, BMMSCs between pas-
sages 1–6 are acceptable. Osteogenesis in MSCs from
both sources occurs using two distinct MAPK pathways.
Understanding the putative signals during osteogenic
differentiation may lead to the understanding of the
osteogenic process that the MSCs undergo and also in
the development of therapies, to achieve an optimal level
of osteogenesis in the treatment of bone related defects.
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